Navigation Links
CVS Caremark Charitable Trust Makes Initial Donation of $100,000 to Relief Effort in Japan
Date:3/15/2011

WOONSOCKET, R.I., March 15, 2011 /PRNewswire/ -- The CVS Caremark Charitable Trust announced today a donation of $100,000 to the American Red Cross in support of relief efforts underway in Japan following last week's tragic earthquake and tsunami, with a potential total donation of up to $300,000 through the matching of CVS Caremark employee donations.

(Logo: http://photos.prnewswire.com/prnh/20101221/NE20875LOGO)

CVS Caremark is working with the Red Cross to establish a dedicated online donation portal for any of its approximately 200,000 employees who want to contribute. The CVS Caremark Charitable Trust will match employee donations up to $100,000.

"With the impact of this terrible event still occurring and given the potential for serious long-term health challenges across northeastern Japan, we are providing support to the American Red Cross as it helps the Japanese Red Cross provide first aid, emotional support and relief items to those who have been displaced," said Eileen Howard Boone, Vice President, CVS Caremark Charitable Trust.

"This contribution from the CVS Caremark Charitable Trust is critically important as we work to provide help and hope to survivors of the Japan earthquake and Pacific tsunami," said Michael J. Brown, Vice President of Corporate and Foundation Giving at the American Red Cross. "In times of disaster, assistance from our corporate partners is key to our ability to fulfill our humanitarian mission."

For information about the American Red Cross, please visit www.redcross.org.

About the CVS Caremark Charitable TrustThe CVS Caremark Charitable Trust, Inc. is a private foundation created by CVS Caremark Corporation (NYSE: CVS).  CVS Caremark is the largest pharmacy health care provider in the United States.  The Trust's mission is to provide funding for health care, education and community involvement initiatives in CVS Caremark communities.  General information about CVS Caremark is available through the Investor Relations section of the Company's web site at http://investor.cvs.com, or through the web site's press room at http://www.cvscaremark.com/newsroom.Contact:Jim Hughes(401) 770-4334jhughes@cvs.com
'/>"/>

SOURCE CVS Caremark Charitable Trust
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year
2. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
3. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
4. CVS Caremark Celebrates Outstanding Pharmacy Care to Patients During American Pharmacists Month in October
5. CVS Caremark Undertakes Multi-Year Study to Improve Patient Medication Adherence
6. CVS Caremark Announces Updates to Flu Vaccine Program
7. CVS Caremarks MinuteClinic and Allina Hospitals & Clinics Form Strategic Partnership
8. CVS Caremark Corporation Increases Quarterly Dividend 15%
9. CVS Caremarks MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission
10. CVS Caremark Names New Chief Human Resources Officer
11. CVS Caremark Corporation Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):